(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.23%) $83.76
(-1.10%) $1.620
(0.09%) $2 344.60
(0.39%) $27.46
(0.66%) $926.60
(-0.30%) $0.932
(-0.20%) $10.96
(-0.40%) $0.799
(-0.17%) $92.16
Live Chart Being Loaded With Signals
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States...
Stats | |
---|---|
Today's Volume | 4 352.00 |
Average Volume | 51 301.00 |
Market Cap | 64.74M |
EPS | $0 ( 2024-02-15 ) |
Next earnings date | ( $-0.0500 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.76 |
ATR14 | $0.0160 (1.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-09 | Obrien Geoffrey | Buy | 84 000 | Employee Stock Option (Right to Buy) |
2024-01-09 | Matsuda Kazuko | Buy | 157 500 | Employee Stock Option (Right to Buy) |
2024-01-09 | Iwaki Yuichi | Buy | 210 000 | Employee Stock Option (Right to Buy) |
2023-08-04 | Lemerond Nicole | Buy | 18 333 | Stock Option (Right to Buy) |
2023-08-04 | Lemerond Nicole | Buy | 0 |
INSIDER POWER |
---|
98.72 |
Last 93 transactions |
Buy: 6 161 551 | Sell: 1 269 768 |
MediciNova Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MediciNova Inc Financials
Annual | 2023 |
Revenue: | $1.00M |
Gross Profit: | $979 705 (97.97 %) |
EPS: | $-0.170 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-5 492.00 (0.00 %) |
EPS: | $-0.0420 |
Q2 | 2023 |
Revenue: | $1.00B |
Gross Profit: | $999.99M (100.00 %) |
EPS: | $-0.0147 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0586 |
Financial Reports:
No articles found.
MediciNova Inc
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators